Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 4Unknown 2Not yet recruiting 2Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 12Stomach Neoplasms 4Colonic Neoplasms 2To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1Rectal Neoplasms 1Platinum Resistant Ovarian Cancer 1Neoplasm Metastasis 1HER2-positive Colorectal Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Advanced Gastric Cancer 1

Interventions

Oxaliplatin 6tislelizumab 3Irinotecan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3sintilimab 2raltitrexed 2pembrolizumab 2Surgical Procedures, Operative 2Specimen Handling 2Neoadjuvant Therapy 2Laparoscopy 2HMPL-013 2spartalizumab 1rimegepant sulfate 1encorafenib 1cemiplimab 1balstilimab 1XELOX 1Surgical Fixation Devices 1Radiofrequency Ablation 1Propranolol 1Preoperative Exercise 1Pemetrexed 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mortality 1Magnetic Resonance Spectroscopy 1Leucovorin 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Colonic Neoplasms × HMPL-013 × Clear all
NCT07510932 2026-04-06

FIRST-K

Korea University Anam Hospital

Phase 2 Not yet recruiting
88 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06218888 2024-01-23

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Fujian Cancer Hospital

Phase 2 Not yet recruiting
17 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡